作者: Alexander Levitzki , Klaus Peter Hirth , Jianming Tsai , Aviv Gazit , Hui Chen
DOI:
关键词:
摘要: The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. is preferably used treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate HER2 EGFR.